CAMP4 Capex To Depreciation vs Pb Ratio Analysis

CAMP Stock

USD 1.95 0.07 3.72%

CAMP4 THERAPEUTICS financial indicator trend analysis is way more than just evaluating CAMP4 THERAPEUTICS prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether CAMP4 THERAPEUTICS is a good investment. Please check the relationship between CAMP4 THERAPEUTICS Capex To Depreciation and its Pb Ratio accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CAMP4 THERAPEUTICS PORATION. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

Capex To Depreciation vs Pb Ratio

Capex To Depreciation vs Pb Ratio Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of CAMP4 THERAPEUTICS Capex To Depreciation account and Pb Ratio. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between CAMP4 THERAPEUTICS's Capex To Depreciation and Pb Ratio is -0.05. Overlapping area represents the amount of variation of Capex To Depreciation that can explain the historical movement of Pb Ratio in the same time period over historical financial statements of CAMP4 THERAPEUTICS PORATION, assuming nothing else is changed. The correlation between historical values of CAMP4 THERAPEUTICS's Capex To Depreciation and Pb Ratio is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capex To Depreciation of CAMP4 THERAPEUTICS PORATION are associated (or correlated) with its Pb Ratio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Pb Ratio has no effect on the direction of Capex To Depreciation i.e., CAMP4 THERAPEUTICS's Capex To Depreciation and Pb Ratio go up and down completely randomly.

Correlation Coefficient

-0.05

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Capex To Depreciation

The ratio of a company's capital expenditures to its depreciation expenses, indicating how much the company is investing in physical assets relative to the aging of existing assets.

Pb Ratio

Most indicators from CAMP4 THERAPEUTICS's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into CAMP4 THERAPEUTICS current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CAMP4 THERAPEUTICS PORATION. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

As of 05/04/2025, Enterprise Value is likely to grow to about 459.2 M, while Selling General Administrative is likely to drop slightly above 14.2 M.

	2022	2024	2025 (projected)
Total Revenue	294.9M	652K	619.4K
Depreciation And Amortization	21.8M	25.0M	26.3M

Total Revenue Depreciation And Amortization

CAMP4 THERAPEUTICS fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Accounts Payable	Common Stock	Good Will	Intangible Assets	Current Deferred Revenue
Total Assets		0.39	-0.58	0.91	0.66	0.68	-0.09	0.37	0.82	0.93	0.7	0.78	0.33	0.61	0.85	0.71	0.76	0.61	0.9	0.94	0.56	0.88	0.35	0.47	0.68	0.39
Short Long Term Debt Total	0.39		-0.15	0.3	-0.09	0.53	0.83	-0.46	0.47	0.36	0.48	0.37	0.91	0.15	0.61	0.62	0.35	0.26	0.55	0.39	0.23	0.21	0.38	0.88	0.55	0.9
Other Current Liab	-0.58	-0.15		-0.42	-0.42	-0.12	0.19	-0.31	-0.56	-0.4	-0.38	-0.59	-0.18	-0.5	-0.5	-0.28	-0.42	-0.32	-0.49	-0.66	-0.02	-0.7	-0.3	-0.04	-0.18	-0.01
Total Current Liabilities	0.91	0.3	-0.42		0.46	0.84	0.01	0.19	0.52	0.98	0.86	0.46	0.26	0.57	0.81	0.64	0.91	0.56	0.89	0.73	0.58	0.91	0.31	0.51	0.6	0.44
Total Stockholder Equity	0.66	-0.09	-0.42	0.46		0.11	-0.51	0.58	0.65	0.48	0.08	0.68	0.01	0.34	0.18	0.39	0.21	0.46	0.26	0.74	0.39	0.49	0.23	-0.11	0.45	-0.09
Property Plant And Equipment Net	0.68	0.53	-0.12	0.84	0.11		0.38	-0.15	0.33	0.83	0.89	0.23	0.4	0.33	0.75	0.56	0.85	0.39	0.81	0.47	0.64	0.61	0.21	0.71	0.48	0.72
Net Debt	-0.09	0.83	0.19	0.01	-0.51	0.38		-0.79	-0.11	0.04	0.33	-0.2	0.79	-0.1	0.24	0.29	0.14	0.0	0.19	-0.16	-0.02	-0.11	0.25	0.76	0.26	0.8
Retained Earnings	0.37	-0.46	-0.31	0.19	0.58	-0.15	-0.79		0.41	0.21	-0.18	0.48	-0.48	0.05	0.1	0.04	-0.04	-0.1	0.13	0.44	0.35	0.25	-0.36	-0.43	0.12	-0.57
Cash	0.82	0.47	-0.56	0.52	0.65	0.33	-0.11	0.41		0.58	0.33	0.96	0.37	0.41	0.69	0.65	0.41	0.49	0.67	0.93	0.43	0.53	0.31	0.37	0.56	0.32
Non Current Assets Total	0.93	0.36	-0.4	0.98	0.48	0.83	0.04	0.21	0.58		0.84	0.5	0.31	0.56	0.84	0.68	0.87	0.56	0.91	0.75	0.58	0.88	0.31	0.57	0.7	0.46
Non Currrent Assets Other	0.7	0.48	-0.38	0.86	0.08	0.89	0.33	-0.18	0.33	0.84		0.24	0.36	0.39	0.81	0.44	0.95	0.4	0.85	0.5	0.33	0.8	0.25	0.64	0.38	0.6
Cash And Short Term Investments	0.78	0.37	-0.59	0.46	0.68	0.23	-0.2	0.48	0.96	0.5	0.24		0.28	0.44	0.63	0.54	0.3	0.47	0.61	0.93	0.39	0.51	0.28	0.22	0.46	0.18
Net Receivables	0.33	0.91	-0.18	0.26	0.01	0.4	0.79	-0.48	0.37	0.31	0.36	0.28		0.31	0.46	0.7	0.22	0.38	0.43	0.34	0.13	0.22	0.57	0.83	0.65	0.85
Common Stock Shares Outstanding	0.61	0.15	-0.5	0.57	0.34	0.33	-0.1	0.05	0.41	0.56	0.39	0.44	0.31		0.55	0.55	0.43	0.83	0.58	0.57	0.15	0.64	0.73	0.26	0.45	0.24
Non Current Liabilities Total	0.85	0.61	-0.5	0.81	0.18	0.75	0.24	0.1	0.69	0.84	0.81	0.63	0.46	0.55		0.67	0.79	0.47	0.99	0.76	0.44	0.76	0.3	0.69	0.59	0.57
Inventory	0.71	0.62	-0.28	0.64	0.39	0.56	0.29	0.04	0.65	0.68	0.44	0.54	0.7	0.55	0.67		0.45	0.65	0.69	0.65	0.58	0.52	0.62	0.75	0.83	0.65
Other Current Assets	0.76	0.35	-0.42	0.91	0.21	0.85	0.14	-0.04	0.41	0.87	0.95	0.3	0.22	0.43	0.79	0.45		0.43	0.86	0.57	0.38	0.84	0.21	0.52	0.38	0.5
Other Stockholder Equity	0.61	0.26	-0.32	0.56	0.46	0.39	0.0	-0.1	0.49	0.56	0.4	0.47	0.38	0.83	0.47	0.65	0.43		0.51	0.57	0.21	0.54	0.9	0.41	0.47	0.39
Total Liab	0.9	0.55	-0.49	0.89	0.26	0.81	0.19	0.13	0.67	0.91	0.85	0.61	0.43	0.58	0.99	0.69	0.86	0.51		0.78	0.5	0.83	0.32	0.67	0.62	0.56
Total Current Assets	0.94	0.39	-0.66	0.73	0.74	0.47	-0.16	0.44	0.93	0.75	0.5	0.93	0.34	0.57	0.76	0.65	0.57	0.57	0.78		0.48	0.76	0.34	0.34	0.6	0.3
Short Term Debt	0.56	0.23	-0.02	0.58	0.39	0.64	-0.02	0.35	0.43	0.58	0.33	0.39	0.13	0.15	0.44	0.58	0.38	0.21	0.5	0.48		0.28	0.0	0.33	0.45	0.32
Accounts Payable	0.88	0.21	-0.7	0.91	0.49	0.61	-0.11	0.25	0.53	0.88	0.8	0.51	0.22	0.64	0.76	0.52	0.84	0.54	0.83	0.76	0.28		0.35	0.35	0.5	0.25
Common Stock	0.35	0.38	-0.3	0.31	0.23	0.21	0.25	-0.36	0.31	0.31	0.25	0.28	0.57	0.73	0.3	0.62	0.21	0.9	0.32	0.34	0.0	0.35		0.48	0.4	0.46
Good Will	0.47	0.88	-0.04	0.51	-0.11	0.71	0.76	-0.43	0.37	0.57	0.64	0.22	0.83	0.26	0.69	0.75	0.52	0.41	0.67	0.34	0.33	0.35	0.48		0.67	0.91
Intangible Assets	0.68	0.55	-0.18	0.6	0.45	0.48	0.26	0.12	0.56	0.7	0.38	0.46	0.65	0.45	0.59	0.83	0.38	0.47	0.62	0.6	0.45	0.5	0.4	0.67		0.54
Current Deferred Revenue	0.39	0.9	-0.01	0.44	-0.09	0.72	0.8	-0.57	0.32	0.46	0.6	0.18	0.85	0.24	0.57	0.65	0.5	0.39	0.56	0.3	0.32	0.25	0.46	0.91	0.54

Click cells to compare fundamentals

CAMP4 THERAPEUTICS Account Relationship Matchups

CAMP4 THERAPEUTICS fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	433.8M	391.6M	380.1M	54.9M	78.3M	74.4M
Short Long Term Debt Total	234.5M	203.5M	205.7M	240.4M	276.5M	290.3M
Other Current Liab	(1.5M)	(1.9M)	(25.1M)	694K	622K	653.1K
Total Current Liabilities	107.2M	90.5M	106.5M	7.8M	9.6M	9.1M
Total Stockholder Equity	95.1M	75.4M	14.3M	(123.7M)	63.1M	66.6M
Property Plant And Equipment Net	55.4M	50.0M	45.1M	13.3M	10.3M	13.2M
Net Debt	127.1M	108.9M	126.4M	198.5M	228.3M	239.7M
Retained Earnings	(138.0M)	(166.0M)	(168.8M)	(160.0M)	(211.8M)	(201.2M)
Cash	94.6M	79.2M	41.9M	38.4M	64.0M	39.0M
Non Current Assets Total	219.5M	210.2M	205.3M	14.9M	11.9M	11.3M
Non Currrent Assets Other	27.2M	29.6M	36.1M	1.6M	1.9M	1.8M
Cash And Short Term Investments	107.4M	94.6M	79.2M	41.9M	48.2M	42.6M
Net Receivables	72.3M	63.3M	61.5M	82.9M	95.4M	100.2M
Common Stock Shares Outstanding	34.4M	35.3M	36.1M	37.0M	20.2M	23.3M
Liabilities And Stockholders Equity	495.8M	433.8M	391.6M	380.1M	437.1M	459.0M
Non Current Liabilities Total	231.5M	225.7M	259.3M	170.9M	5.6M	5.3M
Inventory	36.8M	23.7M	18.3M	23.9M	27.5M	15.1M
Other Current Assets	24.8M	22.3M	26.0M	319K	1.3M	1.2M
Other Stockholder Equity	220.5M	233.7M	242.4M	184.7M	212.4M	112.1M
Total Liab	338.7M	316.2M	365.8M	178.7M	15.2M	14.4M
Total Current Assets	214.3M	181.4M	174.8M	40.0M	66.4M	92.1M
Accumulated Other Comprehensive Income	(1.4M)	(985K)	(1.4M)	(1.9M)	(2.2M)	(2.3M)
Short Term Debt	33.1M	4.3M	2.6M	705K	810.8K	770.2K
Accounts Payable	35.8M	31.8M	52.7M	1.0M	1.2M	1.1M
Common Stock	343K	352K	361K	374K	430.1K	283.2K
Good Will	106.3M	94.6M	94.4M	94.2M	108.3M	58.0M
Intangible Assets	45.9M	37.5M	32.0M	26.6M	30.6M	31.6M
Current Deferred Revenue	34.7M	32.9M	26.2M	25.4M	29.3M	30.7M

Additional Tools for CAMP4 Stock Analysis

When running CAMP4 THERAPEUTICS's price analysis, check to measure CAMP4 THERAPEUTICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CAMP4 THERAPEUTICS is operating at the current time. Most of CAMP4 THERAPEUTICS's value examination focuses on studying past and present price action to predict the probability of CAMP4 THERAPEUTICS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CAMP4 THERAPEUTICS's price. Additionally, you may evaluate how the addition of CAMP4 THERAPEUTICS to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

CAMP4 Capex To Depreciation vs Pb Ratio Analysis

Capex To Depreciation vs Pb Ratio

Capex To Depreciation vs Pb Ratio Correlation Analysis

Correlation Coefficient

Capex To Depreciation

Pb Ratio

CAMP4 THERAPEUTICS fundamental ratios Correlations

CAMP4 THERAPEUTICS Account Relationship Matchups

High Positive Relationship

High Negative Relationship

CAMP4 THERAPEUTICS fundamental ratios Accounts

Additional Tools for CAMP4 Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Liab	+ 0.99	Non Current Liabilities Total
Non Current Assets Total	+ 0.98	Total Current Liabilities
Cash And Short Term Investments	+ 0.96	Cash
Other Current Assets	+ 0.95	Non Currrent Assets Other
Total Current Assets	+ 0.94	Total Assets
Non Current Assets Total	+ 0.93	Total Assets

Retained Earnings	- 0.79	Net Debt
Accounts Payable	- 0.7	Other Current Liab
Total Current Assets	- 0.66	Other Current Liab
Cash And Short Term Investments	- 0.59	Other Current Liab
Other Current Liab	- 0.58	Total Assets
Current Deferred Revenue	- 0.57	Retained Earnings